Sequence Variations in Low Copy Repeats on 22q11.2

22q11.2 上低拷贝重复序列的序列变异

基本信息

  • 批准号:
    7661009
  • 负责人:
  • 金额:
    $ 24.57万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-05-01 至 2011-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Low copy repeats (LCRs; also known as segmental duplications) constitute roughly 5% of the human genome and are known to mediate chromosome rearrangements associated with mental retardation disorders. The long-term goal of our program is to assess the roles in which LCRs confer genome instability using the 22q11.2 region as a model. Non-allelic homologous recombination (NAHR) events between two, 240 kb low copy repeats, termed LCR22-2 and LCR22-4, mapping 3 Mb apart, lead to several genomic disorders including velo-cardio-facial/DiGeorge syndrome (VCFS/DGS), occurring in 1/4,000 live births. Our hypothesis, based upon preliminary data, is that there are clusters of shared polymorphic sequences (SPSs) between the two LCR22s, representing intervals of enhanced historic gene conversion events. Such regions might serve as recombination hotspots responsible for NAHR events. Sequences flanking these clusters would be unique to one LCR or the other and would be marked by paralogous sequence variants (PSVs). PSV based markers could be used to then type VCFS/DGS families to narrow deletion endpoints in the LCR22s to identify hotspots for rearrangements in the future. Although the complete sequence of the two LCR22s is available for two alleles of chromosomes 22 and it allowed us to generate this hypothesis, it is insufficient to test it. To test our hypothesis, we propose to generate the finished sequence of LCR22-2 and -4 from additional normal alleles of chromosome 22 from existing BAC libraries, roughly 4.4 Mb of sequence. In Specific Aim 1, we will characterize the modular domain organization of LCR22-2 and LCR22-4, by generating BAC based physical maps by screening filters containing BAC clones from different libraries, obtaining end sequence and typing with PCR markers. Structural and sequence variation within the two LCR22s has not been defined. In Specific Aim 2, the minimal tiling path of BAC clones encompassing five alleles will be sequenced and a variation map containing all the insertions, deletions or inversions as well as nucleotide polymorphisms, will be generated. In Specific Aim 3, we will test the hypothesis that there are varied regions of historic gene conversion within the LCR22s and will define a set of PSV markers flanking these regions. The PSV markers will be used in the future to type our cohort of 250 VCFS/DGS patients with the typical 3 Mb deletion and their normal parents to identify signatures of genomic instability. Understanding the basis for 22q11.2 rearrangements on the sequence level can serve as a model for other newly discovered genomic disorders, such as the reciprocal duplication disorder on 22q11.2 and elsewhere in the genome. In addition, the detailed maps of the LCR22s will serve as an ideal template for future programs utilizing next generation approaches. PUBLIC HEALTH RELEVANCE: The chromosome 22q11.2 region is associated with multiple developmental disorders. We propose to define unstable regions on 22q11.2 by DNA sequence analysis. This will enable us to understand why chromosomes can rearrange during meiosis resulting in loss or gains in DNA copy number causing birth defects.
描述(由申请人提供):低拷贝重复(lcr,也称为片段重复)约占人类基因组的5%,已知介导与智力迟钝障碍相关的染色体重排。我们项目的长期目标是使用22q11.2区域作为模型来评估lcr赋予基因组不稳定性的作用。两个240 kb低拷贝重复序列LCR22-2和LCR22-4之间的非等位基因同源重组(NAHR)事件,相隔3 Mb,导致几种基因组疾病,包括velo-cardio-facial/DiGeorge综合征(VCFS/DGS),发生在1/4,000活产婴儿中。基于初步数据,我们的假设是,两个lcr22之间存在共享多态性序列(SPSs)集群,代表了增强的历史基因转换事件的间隔。这些区域可能是负责NAHR事件的重组热点。这些集群两侧的序列对于一个LCR或另一个LCR来说是唯一的,并且会被旁系序列变体(psv)标记。基于PSV的标记可用于对VCFS/DGS家族进行分型,以缩小lcr22中的缺失端点,从而确定未来重排的热点。虽然22号染色体的两个等位基因有两个LCR22s的完整序列,这使我们能够产生这个假设,但不足以对其进行验证。为了验证我们的假设,我们建议从现有BAC文库中额外的22号染色体正常等位基因中生成LCR22-2和-4的完整序列,大约有4.4 Mb的序列。在Specific Aim 1中,我们将通过筛选来自不同文库的含有BAC克隆的过滤器,获得末端序列并使用PCR标记分型,生成基于BAC的物理图谱,从而表征LCR22-2和LCR22-4的模块化结构域组织。两个LCR22s的结构和序列变化尚未确定。在Specific Aim 2中,将对包含5个等位基因的BAC克隆的最小平铺路径进行测序,并生成包含所有插入、缺失或反转以及核苷酸多态性的变异图。在Specific Aim 3中,我们将验证lcr22中存在不同历史基因转换区域的假设,并将定义一组位于这些区域两侧的PSV标记。PSV标记将在未来用于对250名典型3mb缺失的VCFS/DGS患者及其正常父母进行分型,以确定基因组不稳定性的特征。在序列水平上理解22q11.2重排的基础可以作为其他新发现的基因组疾病的模型,例如22q11.2和基因组其他地方的互惠重复疾病。此外,lcr22的详细地图将作为利用下一代方法的未来计划的理想模板。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BERNICE E MORROW其他文献

BERNICE E MORROW的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BERNICE E MORROW', 18)}}的其他基金

Molecular pathogenesis of congenital heart disease mediated by neural crest and second heart field cells
神经嵴和第二心野细胞介导先天性心脏病的分子发病机制
  • 批准号:
    10621288
  • 财政年份:
    2022
  • 资助金额:
    $ 24.57万
  • 项目类别:
Genetic modifiers of congenital heart disease in 22q11.2 deletion syndrome
22q11.2缺失综合征先天性心脏病的遗传修饰
  • 批准号:
    10373375
  • 财政年份:
    2022
  • 资助金额:
    $ 24.57万
  • 项目类别:
Genetic modifiers of congenital heart disease in 22q11.2 deletion syndrome
22q11.2缺失综合征先天性心脏病的遗传修饰
  • 批准号:
    10553279
  • 财政年份:
    2022
  • 资助金额:
    $ 24.57万
  • 项目类别:
Molecular pathogenesis of congenital heart disease mediated by neural crest and second heart field cells
神经嵴和第二心野细胞介导先天性心脏病的分子发病机制
  • 批准号:
    10435713
  • 财政年份:
    2022
  • 资助金额:
    $ 24.57万
  • 项目类别:
NEUROGENOMICS CORE
神经基因组学核心
  • 批准号:
    10239750
  • 财政年份:
    2021
  • 资助金额:
    $ 24.57万
  • 项目类别:
NEUROGENOMICS CORE
神经基因组学核心
  • 批准号:
    10455677
  • 财政年份:
    2021
  • 资助金额:
    $ 24.57万
  • 项目类别:
Molecular and cellular mechanisms in cardiac outflow tract formation and defects
心脏流出道形成和缺陷的分子和细胞机制
  • 批准号:
    10289982
  • 财政年份:
    2021
  • 资助金额:
    $ 24.57万
  • 项目类别:
NEUROGENOMICS CORE
神经基因组学核心
  • 批准号:
    10669066
  • 财政年份:
    2021
  • 资助金额:
    $ 24.57万
  • 项目类别:
Molecular and cellular mechanisms in cardiac outflow tract formation and defects
心脏流出道形成和缺陷的分子和细胞机制
  • 批准号:
    10471433
  • 财政年份:
    2021
  • 资助金额:
    $ 24.57万
  • 项目类别:
Cell fate choices by Tbx1 in forming the mammalian heart
Tbx1 在形成哺乳动物心脏过程中的细胞命运选择
  • 批准号:
    10615781
  • 财政年份:
    2020
  • 资助金额:
    $ 24.57万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 24.57万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 24.57万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 24.57万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 24.57万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 24.57万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 24.57万
  • 项目类别:
    Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 24.57万
  • 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 24.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 24.57万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 24.57万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了